The Biological SCENE A research team led by Jayachandran N. Kizhakkedathu of the University of British Columbia recently designed a reversal agent for heparin (Sci. Tr...
Scientific American For the past 20 years pregnant women with an increased risk of developing blood clots have often been prescribed a common blood thinner to prevent se...
KSHB By injecting patients with the blood-thinner Heparin and clot-busting agent TPA, doctors found that they could open up the tiny blood vessels often damaged by frostbite, and otherwise almost impossible to treat. Recent studies have supported the use of ...
GlobeNewswire (press release) Heparin is the most widely used anticoagulant and is used for most surgeries and the dissolution of blood clots. Approximately 12 million patients in the U.S. are exposed to heparin annually. Certain patients have life- and limb-threatening allergic ... and more »
Rock Hill Herald (press release) While adding nothing to the blood, Seraph uses a biomimetic 'adsorption media' that includes chemically-bonded heparin and supplemental adsorbent materials in a single cartridge. The well-known anti-thrombogenic properties of heparin contribute to the ...
TCTMD Anticoagulation with bivalirudin compared with heparin plus a glycoprotein IIb/IIIa inhibitor (GPI) reduces cardiac mortality and bleeding in STEMI patients undergoing primary PCI at the cost of more acute stent thrombosis, according to a patient-level ...
Digital Journal Most up-to-date research on "China Heparin Industry Report, 2014-2017" to its huge collection of research reports. Albany, NY -- (ReleaseWire) -- 12/12/2014 -- As the world's major heparin API producer and exporter, China boasts enormous raw materials, ...
Digital Journal The Report China Heparin Industry Report, 2014-2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz. Albany, NY -- (ReleaseWire) -- 12/31/2014 -- As the ... and more »
Nasdaq (RTTNews.com) - Akers Biosciences, Inc. (AKER, AKR.L), a manufacturer of rapid diagnostic screening and testing products, Thursday said it has entered into multi-...
Philadelphia Business Journal (blog) The company's PIFA Heparin /PF4 Rapid Assay product is used to determine whether a patient has a condition known as heparin -induc...
